INVITRO ANTIMICROBIAL ACTIVITY OF CEFOPERAZONE SULBACTAM COMBINATIONS AGAINST 554 CLINICAL ISOLATES INCLUDING A REVIEW AND BETA-LACTAMASE STUDIES

被引：28

作者：

JONES, RN

WILSON, HW

THORNSBERRY, C

BARRY, AL

机构：

来源：

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 1985年 / 3卷 / 06期

关键词：

D O I：

10.1016/S0732-8893(85)80005-5

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

收藏

页码：489 / 499

页数：11

相关论文

共 21 条

[1] RO 13-9904, A LONG-ACTING BROAD-SPECTRUM CEPHALOSPORIN - INVITRO AND INVIVO STUDIES
ANGEHRN, P
PROBST, PJ
REINER, R
THEN, RL
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 18 (06) : 913 - 921
[2] INVITRO ANTI-MICROBIAL ACTIVITY OF CEFOPERAZONE, CEFOTAXIME, MOXALACTAM (LY127935), AZLOCILLIN, MEZLOCILLIN, AND OTHER BETA-LACTAM ANTIBIOTICS AGAINST NEISSERIA-GONORRHOEAE AND HEMOPHILUS-INFLUENZAE, INCLUDING BETA-LACTAMASE-PRODUCING STRAINS
BAKER, CN
THORNSBERRY, C
JONES, RN
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 17 (04) : 757 - 761
[3] BRENNER DG, 1981, MOL BASIS DRUG ACTIO, P335
[4] BROGDEN RN, 1981, DRUGS, V22, P421
[5] ACTIVITY OF CEFOPERAZONE AND 2 BETA-LACTAMASE INHIBITORS, SULBACTAM AND CLAVULANIC ACID, AGAINST BACTEROIDES SPP CORRELATED WITH BETA-LACTAMASE PRODUCTION
CROSBY, MA
GUMP, DW
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (03) : 398 - 405
[6] CP-45,899, A BETA-LACTAMASE INHIBITOR THAT EXTENDS ANTIBACTERIAL SPECTRUM OF BETA-LACTAMS - INITIAL BACTERIOLOGICAL CHARACTERIZATION
ENGLISH, AR
RETSEMA, JA
GIRARD, AE
LYNCH, JE
BARTH, WE
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1978, 14 (03) : 414 - 419
[7] COMPARATIVE INHIBITION OF BETA-LACTAMASES BY NOVEL BETA-LACTAM COMPOUNDS
FU, KP
NEU, HC
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 15 (02) : 171 - 176
[8] FU KP, 1980, J ANTIMICROB CHEMOTH, V7, P287
[9] CEFOTAXIME - INVITRO ACTIVITY AND TENTATIVE INTERPRETIVE STANDARDS FOR DISK SUSCEPTIBILITY TESTING
FUCHS, PC
BARRY, AL
THORNSBERRY, C
JONES, RN
GAVAN, TL
GERLACH, EH
SOMMERS, HM
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 18 (01) : 88 - 93
[10] JONES RN, 1983, REV INFECT DIS, V5, pS108